nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—PTGIR—pulmonary artery—systemic scleroderma	0.0754	0.23	CbGeAlD
Treprostinil—CYP2C9—cardial valve—systemic scleroderma	0.0666	0.203	CbGeAlD
Treprostinil—P2RY12—artery—systemic scleroderma	0.0438	0.134	CbGeAlD
Treprostinil—PTGIR—artery—systemic scleroderma	0.028	0.0854	CbGeAlD
Treprostinil—PTGIR—endothelium—systemic scleroderma	0.0236	0.0721	CbGeAlD
Treprostinil—PTGIR—blood vessel—systemic scleroderma	0.0218	0.0665	CbGeAlD
Treprostinil—PTGIR—connective tissue—systemic scleroderma	0.0112	0.0341	CbGeAlD
Treprostinil—PPARD—digestive system—systemic scleroderma	0.0105	0.0321	CbGeAlD
Treprostinil—PTGIR—smooth muscle tissue—systemic scleroderma	0.0102	0.0312	CbGeAlD
Treprostinil—PPARD—tendon—systemic scleroderma	0.00999	0.0305	CbGeAlD
Treprostinil—PPARD—lung—systemic scleroderma	0.00877	0.0268	CbGeAlD
Treprostinil—PTGIR—digestive system—systemic scleroderma	0.00806	0.0246	CbGeAlD
Treprostinil—PTGIR—lung—systemic scleroderma	0.00673	0.0206	CbGeAlD
Treprostinil—CYP2C9—digestive system—systemic scleroderma	0.00288	0.0088	CbGeAlD
Treprostinil—Tachycardia—Leflunomide—systemic scleroderma	0.00103	0.00154	CcSEcCtD
Treprostinil—Anaemia—Lisinopril—systemic scleroderma	0.00103	0.00153	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00102	0.00152	CcSEcCtD
Treprostinil—Angioedema—Lisinopril—systemic scleroderma	0.00102	0.00151	CcSEcCtD
Treprostinil—Body temperature increased—Captopril—systemic scleroderma	0.00102	0.00151	CcSEcCtD
Treprostinil—Abdominal pain—Captopril—systemic scleroderma	0.00102	0.00151	CcSEcCtD
Treprostinil—Oedema—Mycophenolic acid—systemic scleroderma	0.00101	0.0015	CcSEcCtD
Treprostinil—Anorexia—Leflunomide—systemic scleroderma	0.00101	0.0015	CcSEcCtD
Treprostinil—Nausea—Pentoxifylline—systemic scleroderma	0.00101	0.0015	CcSEcCtD
Treprostinil—Malaise—Lisinopril—systemic scleroderma	0.00101	0.00149	CcSEcCtD
Treprostinil—Infection—Mycophenolic acid—systemic scleroderma	0.001	0.00149	CcSEcCtD
Treprostinil—Diarrhoea—Mometasone—systemic scleroderma	0.001	0.00149	CcSEcCtD
Treprostinil—Hypokalaemia—Prednisone—systemic scleroderma	0.001	0.00149	CcSEcCtD
Treprostinil—Syncope—Lisinopril—systemic scleroderma	0.001	0.00149	CcSEcCtD
Treprostinil—Shock—Mycophenolic acid—systemic scleroderma	0.000994	0.00148	CcSEcCtD
Treprostinil—Hypotension—Leflunomide—systemic scleroderma	0.000989	0.00147	CcSEcCtD
Treprostinil—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000989	0.00147	CcSEcCtD
Treprostinil—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000986	0.00147	CcSEcCtD
Treprostinil—Palpitations—Lisinopril—systemic scleroderma	0.000985	0.00146	CcSEcCtD
Treprostinil—Loss of consciousness—Lisinopril—systemic scleroderma	0.00098	0.00146	CcSEcCtD
Treprostinil—Cough—Lisinopril—systemic scleroderma	0.000973	0.00145	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000965	0.00143	CcSEcCtD
Treprostinil—Anorexia—Mycophenolic acid—systemic scleroderma	0.000963	0.00143	CcSEcCtD
Treprostinil—Tension—Mycophenolate mofetil—systemic scleroderma	0.000958	0.00142	CcSEcCtD
Treprostinil—Insomnia—Leflunomide—systemic scleroderma	0.000958	0.00142	CcSEcCtD
Treprostinil—Paraesthesia—Leflunomide—systemic scleroderma	0.000951	0.00141	CcSEcCtD
Treprostinil—Arthralgia—Lisinopril—systemic scleroderma	0.000949	0.00141	CcSEcCtD
Treprostinil—Chest pain—Lisinopril—systemic scleroderma	0.000949	0.00141	CcSEcCtD
Treprostinil—Myalgia—Lisinopril—systemic scleroderma	0.000949	0.00141	CcSEcCtD
Treprostinil—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000949	0.00141	CcSEcCtD
Treprostinil—Anxiety—Lisinopril—systemic scleroderma	0.000946	0.00141	CcSEcCtD
Treprostinil—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000945	0.0014	CcSEcCtD
Treprostinil—Dyspnoea—Leflunomide—systemic scleroderma	0.000944	0.0014	CcSEcCtD
Treprostinil—Hypotension—Mycophenolic acid—systemic scleroderma	0.000944	0.0014	CcSEcCtD
Treprostinil—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000939	0.0014	CcSEcCtD
Treprostinil—Discomfort—Lisinopril—systemic scleroderma	0.000938	0.00139	CcSEcCtD
Treprostinil—Dyspepsia—Leflunomide—systemic scleroderma	0.000932	0.00139	CcSEcCtD
Treprostinil—Vomiting—Mometasone—systemic scleroderma	0.00093	0.00138	CcSEcCtD
Treprostinil—Feeling abnormal—Azathioprine—systemic scleroderma	0.000924	0.00137	CcSEcCtD
Treprostinil—Rash—Mometasone—systemic scleroderma	0.000922	0.00137	CcSEcCtD
Treprostinil—Asthenia—Captopril—systemic scleroderma	0.000922	0.00137	CcSEcCtD
Treprostinil—Dermatitis—Mometasone—systemic scleroderma	0.000921	0.00137	CcSEcCtD
Treprostinil—Decreased appetite—Leflunomide—systemic scleroderma	0.00092	0.00137	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00092	0.00137	CcSEcCtD
Treprostinil—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000917	0.00136	CcSEcCtD
Treprostinil—Headache—Mometasone—systemic scleroderma	0.000916	0.00136	CcSEcCtD
Treprostinil—Insomnia—Mycophenolic acid—systemic scleroderma	0.000913	0.00136	CcSEcCtD
Treprostinil—Fatigue—Leflunomide—systemic scleroderma	0.000913	0.00136	CcSEcCtD
Treprostinil—Oedema—Lisinopril—systemic scleroderma	0.00091	0.00135	CcSEcCtD
Treprostinil—Pruritus—Captopril—systemic scleroderma	0.000909	0.00135	CcSEcCtD
Treprostinil—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000907	0.00135	CcSEcCtD
Treprostinil—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000906	0.00135	CcSEcCtD
Treprostinil—Pain—Leflunomide—systemic scleroderma	0.000905	0.00135	CcSEcCtD
Treprostinil—Infection—Lisinopril—systemic scleroderma	0.000904	0.00134	CcSEcCtD
Treprostinil—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000903	0.00134	CcSEcCtD
Treprostinil—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.0009	0.00134	CcSEcCtD
Treprostinil—Shock—Lisinopril—systemic scleroderma	0.000895	0.00133	CcSEcCtD
Treprostinil—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000892	0.00133	CcSEcCtD
Treprostinil—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000891	0.00132	CcSEcCtD
Treprostinil—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000889	0.00132	CcSEcCtD
Treprostinil—Tachycardia—Lisinopril—systemic scleroderma	0.000888	0.00132	CcSEcCtD
Treprostinil—Body temperature increased—Azathioprine—systemic scleroderma	0.000886	0.00132	CcSEcCtD
Treprostinil—Abdominal pain—Azathioprine—systemic scleroderma	0.000886	0.00132	CcSEcCtD
Treprostinil—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000881	0.00131	CcSEcCtD
Treprostinil—Diarrhoea—Captopril—systemic scleroderma	0.000879	0.00131	CcSEcCtD
Treprostinil—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000878	0.00131	CcSEcCtD
Treprostinil—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000876	0.0013	CcSEcCtD
Treprostinil—Feeling abnormal—Leflunomide—systemic scleroderma	0.000872	0.0013	CcSEcCtD
Treprostinil—Fatigue—Mycophenolic acid—systemic scleroderma	0.000871	0.00129	CcSEcCtD
Treprostinil—Nausea—Mometasone—systemic scleroderma	0.000869	0.00129	CcSEcCtD
Treprostinil—Anorexia—Lisinopril—systemic scleroderma	0.000867	0.00129	CcSEcCtD
Treprostinil—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000866	0.00129	CcSEcCtD
Treprostinil—Pain—Mycophenolic acid—systemic scleroderma	0.000864	0.00128	CcSEcCtD
Treprostinil—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000863	0.00128	CcSEcCtD
Treprostinil—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000858	0.00128	CcSEcCtD
Treprostinil—Cough—Mycophenolate mofetil—systemic scleroderma	0.000852	0.00127	CcSEcCtD
Treprostinil—Hypotension—Lisinopril—systemic scleroderma	0.00085	0.00126	CcSEcCtD
Treprostinil—Dizziness—Captopril—systemic scleroderma	0.000849	0.00126	CcSEcCtD
Treprostinil—Depression—Prednisone—systemic scleroderma	0.000845	0.00126	CcSEcCtD
Treprostinil—Abdominal pain—Leflunomide—systemic scleroderma	0.000837	0.00124	CcSEcCtD
Treprostinil—Body temperature increased—Leflunomide—systemic scleroderma	0.000837	0.00124	CcSEcCtD
Treprostinil—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000832	0.00124	CcSEcCtD
Treprostinil—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000831	0.00124	CcSEcCtD
Treprostinil—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000831	0.00124	CcSEcCtD
Treprostinil—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000831	0.00124	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000829	0.00123	CcSEcCtD
Treprostinil—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000829	0.00123	CcSEcCtD
Treprostinil—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000826	0.00123	CcSEcCtD
Treprostinil—Insomnia—Lisinopril—systemic scleroderma	0.000823	0.00122	CcSEcCtD
Treprostinil—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000821	0.00122	CcSEcCtD
Treprostinil—Paraesthesia—Lisinopril—systemic scleroderma	0.000817	0.00121	CcSEcCtD
Treprostinil—Vomiting—Captopril—systemic scleroderma	0.000817	0.00121	CcSEcCtD
Treprostinil—Dyspnoea—Lisinopril—systemic scleroderma	0.000811	0.00121	CcSEcCtD
Treprostinil—Rash—Captopril—systemic scleroderma	0.00081	0.0012	CcSEcCtD
Treprostinil—Dermatitis—Captopril—systemic scleroderma	0.000809	0.0012	CcSEcCtD
Treprostinil—Headache—Captopril—systemic scleroderma	0.000805	0.0012	CcSEcCtD
Treprostinil—Dyspepsia—Lisinopril—systemic scleroderma	0.000801	0.00119	CcSEcCtD
Treprostinil—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000798	0.00119	CcSEcCtD
Treprostinil—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000798	0.00119	CcSEcCtD
Treprostinil—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000797	0.00119	CcSEcCtD
Treprostinil—Infection—Mycophenolate mofetil—systemic scleroderma	0.000792	0.00118	CcSEcCtD
Treprostinil—Decreased appetite—Lisinopril—systemic scleroderma	0.000791	0.00118	CcSEcCtD
Treprostinil—Fatigue—Lisinopril—systemic scleroderma	0.000784	0.00117	CcSEcCtD
Treprostinil—Shock—Mycophenolate mofetil—systemic scleroderma	0.000784	0.00117	CcSEcCtD
Treprostinil—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00078	0.00116	CcSEcCtD
Treprostinil—Pain—Lisinopril—systemic scleroderma	0.000778	0.00116	CcSEcCtD
Treprostinil—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000778	0.00116	CcSEcCtD
Treprostinil—Bradycardia—Prednisone—systemic scleroderma	0.000774	0.00115	CcSEcCtD
Treprostinil—Diarrhoea—Azathioprine—systemic scleroderma	0.000767	0.00114	CcSEcCtD
Treprostinil—Haemoglobin—Prednisone—systemic scleroderma	0.000764	0.00114	CcSEcCtD
Treprostinil—Nausea—Captopril—systemic scleroderma	0.000763	0.00113	CcSEcCtD
Treprostinil—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000761	0.00113	CcSEcCtD
Treprostinil—Haemorrhage—Prednisone—systemic scleroderma	0.00076	0.00113	CcSEcCtD
Treprostinil—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00076	0.00113	CcSEcCtD
Treprostinil—Asthenia—Leflunomide—systemic scleroderma	0.00076	0.00113	CcSEcCtD
Treprostinil—Feeling abnormal—Lisinopril—systemic scleroderma	0.00075	0.00111	CcSEcCtD
Treprostinil—Pruritus—Leflunomide—systemic scleroderma	0.000749	0.00111	CcSEcCtD
Treprostinil—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000745	0.00111	CcSEcCtD
Treprostinil—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000744	0.00111	CcSEcCtD
Treprostinil—Dizziness—Azathioprine—systemic scleroderma	0.000741	0.0011	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000726	0.00108	CcSEcCtD
Treprostinil—Asthenia—Mycophenolic acid—systemic scleroderma	0.000725	0.00108	CcSEcCtD
Treprostinil—Diarrhoea—Leflunomide—systemic scleroderma	0.000724	0.00108	CcSEcCtD
Treprostinil—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000721	0.00107	CcSEcCtD
Treprostinil—Body temperature increased—Lisinopril—systemic scleroderma	0.000719	0.00107	CcSEcCtD
Treprostinil—Abdominal pain—Lisinopril—systemic scleroderma	0.000719	0.00107	CcSEcCtD
Treprostinil—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000716	0.00106	CcSEcCtD
Treprostinil—Pruritus—Mycophenolic acid—systemic scleroderma	0.000715	0.00106	CcSEcCtD
Treprostinil—Vomiting—Azathioprine—systemic scleroderma	0.000713	0.00106	CcSEcCtD
Treprostinil—Pneumonia—Methotrexate—systemic scleroderma	0.000712	0.00106	CcSEcCtD
Treprostinil—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000711	0.00106	CcSEcCtD
Treprostinil—Rash—Azathioprine—systemic scleroderma	0.000707	0.00105	CcSEcCtD
Treprostinil—Dermatitis—Azathioprine—systemic scleroderma	0.000706	0.00105	CcSEcCtD
Treprostinil—Depression—Methotrexate—systemic scleroderma	0.000706	0.00105	CcSEcCtD
Treprostinil—Flushing—Prednisone—systemic scleroderma	0.000706	0.00105	CcSEcCtD
Treprostinil—Headache—Azathioprine—systemic scleroderma	0.000702	0.00104	CcSEcCtD
Treprostinil—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000702	0.00104	CcSEcCtD
Treprostinil—Dizziness—Leflunomide—systemic scleroderma	0.0007	0.00104	CcSEcCtD
Treprostinil—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000693	0.00103	CcSEcCtD
Treprostinil—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000691	0.00103	CcSEcCtD
Treprostinil—Pain—Mycophenolate mofetil—systemic scleroderma	0.000682	0.00101	CcSEcCtD
Treprostinil—Haematuria—Methotrexate—systemic scleroderma	0.000675	0.001	CcSEcCtD
Treprostinil—Vomiting—Leflunomide—systemic scleroderma	0.000673	0.001	CcSEcCtD
Treprostinil—Dizziness—Mycophenolic acid—systemic scleroderma	0.000668	0.000993	CcSEcCtD
Treprostinil—Epistaxis—Methotrexate—systemic scleroderma	0.000668	0.000993	CcSEcCtD
Treprostinil—Rash—Leflunomide—systemic scleroderma	0.000668	0.000993	CcSEcCtD
Treprostinil—Dermatitis—Leflunomide—systemic scleroderma	0.000667	0.000992	CcSEcCtD
Treprostinil—Nausea—Azathioprine—systemic scleroderma	0.000666	0.00099	CcSEcCtD
Treprostinil—Headache—Leflunomide—systemic scleroderma	0.000663	0.000986	CcSEcCtD
Treprostinil—Erythema—Prednisone—systemic scleroderma	0.000662	0.000984	CcSEcCtD
Treprostinil—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000657	0.000977	CcSEcCtD
Treprostinil—Asthenia—Lisinopril—systemic scleroderma	0.000653	0.00097	CcSEcCtD
Treprostinil—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000652	0.000969	CcSEcCtD
Treprostinil—Pruritus—Lisinopril—systemic scleroderma	0.000644	0.000957	CcSEcCtD
Treprostinil—Vomiting—Mycophenolic acid—systemic scleroderma	0.000642	0.000955	CcSEcCtD
Treprostinil—Haemoglobin—Methotrexate—systemic scleroderma	0.000639	0.00095	CcSEcCtD
Treprostinil—Rash—Mycophenolic acid—systemic scleroderma	0.000637	0.000947	CcSEcCtD
Treprostinil—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000636	0.000946	CcSEcCtD
Treprostinil—Haemorrhage—Methotrexate—systemic scleroderma	0.000636	0.000945	CcSEcCtD
Treprostinil—Headache—Mycophenolic acid—systemic scleroderma	0.000633	0.000941	CcSEcCtD
Treprostinil—Pharyngitis—Methotrexate—systemic scleroderma	0.000631	0.000938	CcSEcCtD
Treprostinil—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00063	0.000937	CcSEcCtD
Treprostinil—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00063	0.000937	CcSEcCtD
Treprostinil—Nausea—Leflunomide—systemic scleroderma	0.000629	0.000935	CcSEcCtD
Treprostinil—Diarrhoea—Lisinopril—systemic scleroderma	0.000622	0.000925	CcSEcCtD
Treprostinil—Ill-defined disorder—Prednisone—systemic scleroderma	0.000614	0.000913	CcSEcCtD
Treprostinil—Anaemia—Prednisone—systemic scleroderma	0.000612	0.00091	CcSEcCtD
Treprostinil—Angioedema—Prednisone—systemic scleroderma	0.000605	0.000899	CcSEcCtD
Treprostinil—Dizziness—Lisinopril—systemic scleroderma	0.000602	0.000894	CcSEcCtD
Treprostinil—Nausea—Mycophenolic acid—systemic scleroderma	0.0006	0.000892	CcSEcCtD
Treprostinil—Malaise—Prednisone—systemic scleroderma	0.000597	0.000888	CcSEcCtD
Treprostinil—Syncope—Prednisone—systemic scleroderma	0.000594	0.000883	CcSEcCtD
Treprostinil—Loss of consciousness—Prednisone—systemic scleroderma	0.000582	0.000865	CcSEcCtD
Treprostinil—Vomiting—Lisinopril—systemic scleroderma	0.000578	0.00086	CcSEcCtD
Treprostinil—Rash—Lisinopril—systemic scleroderma	0.000574	0.000853	CcSEcCtD
Treprostinil—Dermatitis—Lisinopril—systemic scleroderma	0.000573	0.000852	CcSEcCtD
Treprostinil—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000572	0.00085	CcSEcCtD
Treprostinil—Headache—Lisinopril—systemic scleroderma	0.00057	0.000847	CcSEcCtD
Treprostinil—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000564	0.000838	CcSEcCtD
Treprostinil—Myalgia—Prednisone—systemic scleroderma	0.000564	0.000838	CcSEcCtD
Treprostinil—Arthralgia—Prednisone—systemic scleroderma	0.000564	0.000838	CcSEcCtD
Treprostinil—Anxiety—Prednisone—systemic scleroderma	0.000562	0.000835	CcSEcCtD
Treprostinil—Discomfort—Prednisone—systemic scleroderma	0.000557	0.000828	CcSEcCtD
Treprostinil—Erythema—Methotrexate—systemic scleroderma	0.000553	0.000823	CcSEcCtD
Treprostinil—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000545	0.000811	CcSEcCtD
Treprostinil—Nausea—Lisinopril—systemic scleroderma	0.00054	0.000803	CcSEcCtD
Treprostinil—Oedema—Prednisone—systemic scleroderma	0.00054	0.000803	CcSEcCtD
Treprostinil—Infection—Prednisone—systemic scleroderma	0.000537	0.000798	CcSEcCtD
Treprostinil—Back pain—Methotrexate—systemic scleroderma	0.000535	0.000796	CcSEcCtD
Treprostinil—Shock—Prednisone—systemic scleroderma	0.000532	0.00079	CcSEcCtD
Treprostinil—Tachycardia—Prednisone—systemic scleroderma	0.000527	0.000784	CcSEcCtD
Treprostinil—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000527	0.000784	CcSEcCtD
Treprostinil—Anorexia—Prednisone—systemic scleroderma	0.000515	0.000766	CcSEcCtD
Treprostinil—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000513	0.000763	CcSEcCtD
Treprostinil—Anaemia—Methotrexate—systemic scleroderma	0.000511	0.00076	CcSEcCtD
Treprostinil—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000507	0.000754	CcSEcCtD
Treprostinil—Rash—Mycophenolate mofetil—systemic scleroderma	0.000503	0.000747	CcSEcCtD
Treprostinil—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000502	0.000747	CcSEcCtD
Treprostinil—Headache—Mycophenolate mofetil—systemic scleroderma	0.000499	0.000742	CcSEcCtD
Treprostinil—Malaise—Methotrexate—systemic scleroderma	0.000499	0.000742	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000492	0.000732	CcSEcCtD
Treprostinil—Insomnia—Prednisone—systemic scleroderma	0.000489	0.000727	CcSEcCtD
Treprostinil—Paraesthesia—Prednisone—systemic scleroderma	0.000485	0.000721	CcSEcCtD
Treprostinil—Cough—Methotrexate—systemic scleroderma	0.000483	0.000718	CcSEcCtD
Treprostinil—Dyspepsia—Prednisone—systemic scleroderma	0.000476	0.000707	CcSEcCtD
Treprostinil—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000473	0.000704	CcSEcCtD
Treprostinil—Myalgia—Methotrexate—systemic scleroderma	0.000471	0.0007	CcSEcCtD
Treprostinil—Arthralgia—Methotrexate—systemic scleroderma	0.000471	0.0007	CcSEcCtD
Treprostinil—Chest pain—Methotrexate—systemic scleroderma	0.000471	0.0007	CcSEcCtD
Treprostinil—Decreased appetite—Prednisone—systemic scleroderma	0.00047	0.000698	CcSEcCtD
Treprostinil—Fatigue—Prednisone—systemic scleroderma	0.000466	0.000693	CcSEcCtD
Treprostinil—Discomfort—Methotrexate—systemic scleroderma	0.000465	0.000692	CcSEcCtD
Treprostinil—Infection—Methotrexate—systemic scleroderma	0.000449	0.000667	CcSEcCtD
Treprostinil—Feeling abnormal—Prednisone—systemic scleroderma	0.000445	0.000662	CcSEcCtD
Treprostinil—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000442	0.000657	CcSEcCtD
Treprostinil—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000442	0.000657	CcSEcCtD
Treprostinil—Anorexia—Methotrexate—systemic scleroderma	0.00043	0.00064	CcSEcCtD
Treprostinil—Abdominal pain—Prednisone—systemic scleroderma	0.000427	0.000635	CcSEcCtD
Treprostinil—Body temperature increased—Prednisone—systemic scleroderma	0.000427	0.000635	CcSEcCtD
Treprostinil—Hypotension—Methotrexate—systemic scleroderma	0.000422	0.000627	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000411	0.000612	CcSEcCtD
Treprostinil—Insomnia—Methotrexate—systemic scleroderma	0.000408	0.000607	CcSEcCtD
Treprostinil—Paraesthesia—Methotrexate—systemic scleroderma	0.000405	0.000603	CcSEcCtD
Treprostinil—Dyspnoea—Methotrexate—systemic scleroderma	0.000403	0.000599	CcSEcCtD
Treprostinil—Dyspepsia—Methotrexate—systemic scleroderma	0.000397	0.000591	CcSEcCtD
Treprostinil—Decreased appetite—Methotrexate—systemic scleroderma	0.000393	0.000584	CcSEcCtD
Treprostinil—Fatigue—Methotrexate—systemic scleroderma	0.000389	0.000579	CcSEcCtD
Treprostinil—Asthenia—Prednisone—systemic scleroderma	0.000388	0.000576	CcSEcCtD
Treprostinil—Pain—Methotrexate—systemic scleroderma	0.000386	0.000574	CcSEcCtD
Treprostinil—Pruritus—Prednisone—systemic scleroderma	0.000382	0.000568	CcSEcCtD
Treprostinil—Feeling abnormal—Methotrexate—systemic scleroderma	0.000372	0.000553	CcSEcCtD
Treprostinil—Diarrhoea—Prednisone—systemic scleroderma	0.00037	0.00055	CcSEcCtD
Treprostinil—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000369	0.000549	CcSEcCtD
Treprostinil—Dizziness—Prednisone—systemic scleroderma	0.000357	0.000531	CcSEcCtD
Treprostinil—Abdominal pain—Methotrexate—systemic scleroderma	0.000357	0.000531	CcSEcCtD
Treprostinil—Body temperature increased—Methotrexate—systemic scleroderma	0.000357	0.000531	CcSEcCtD
Treprostinil—Vomiting—Prednisone—systemic scleroderma	0.000344	0.000511	CcSEcCtD
Treprostinil—Rash—Prednisone—systemic scleroderma	0.000341	0.000507	CcSEcCtD
Treprostinil—Dermatitis—Prednisone—systemic scleroderma	0.00034	0.000506	CcSEcCtD
Treprostinil—Headache—Prednisone—systemic scleroderma	0.000338	0.000503	CcSEcCtD
Treprostinil—Asthenia—Methotrexate—systemic scleroderma	0.000324	0.000482	CcSEcCtD
Treprostinil—Nausea—Prednisone—systemic scleroderma	0.000321	0.000477	CcSEcCtD
Treprostinil—Pruritus—Methotrexate—systemic scleroderma	0.000319	0.000475	CcSEcCtD
Treprostinil—Diarrhoea—Methotrexate—systemic scleroderma	0.000309	0.000459	CcSEcCtD
Treprostinil—Dizziness—Methotrexate—systemic scleroderma	0.000299	0.000444	CcSEcCtD
Treprostinil—Vomiting—Methotrexate—systemic scleroderma	0.000287	0.000427	CcSEcCtD
Treprostinil—Rash—Methotrexate—systemic scleroderma	0.000285	0.000423	CcSEcCtD
Treprostinil—Dermatitis—Methotrexate—systemic scleroderma	0.000284	0.000423	CcSEcCtD
Treprostinil—Headache—Methotrexate—systemic scleroderma	0.000283	0.000421	CcSEcCtD
Treprostinil—Nausea—Methotrexate—systemic scleroderma	0.000268	0.000399	CcSEcCtD
